Minerva Neurosciences (NERV)
(Delayed Data from NSDQ)
$1.84 USD
-0.05 (-2.78%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $1.81 -0.03 (-1.63%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth B Momentum D VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
NERV 1.84 -0.05(-2.78%)
Will NERV be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for NERV based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for NERV
Minerva Neurosciences Reports Q1 2025 Earnings and Regulatory Challenges
NERV's Cash Reserves Decrease by $4.1 Million in Q1 2025 | NERV Stock News
Minerva Neurosciences GAAP EPS of -$0.50
Minerva Neurosciences Reports First Quarter 2025 Financial Results and Business Updates | NERV ...
Minerva reports Q1 EPS (50c) vs ($1.13) last year